BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38148644)

  • 21. miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma.
    Zhou P; Jiang W; Wu L; Chang R; Wu K; Wang Z
    Dig Dis Sci; 2012 May; 57(5):1171-80. PubMed ID: 22373864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
    Hu J; Ruan J; Liu X; Xiao C; Xiong J
    Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
    Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer.
    Peng LN; Shi WT; Feng HR; Wei CY; Yin QN
    Innate Immun; 2019 May; 25(4):217-223. PubMed ID: 30943822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a.
    Lv L; Jia JQ; Chen J
    Oncol Res; 2018 Mar; 26(2):201-208. PubMed ID: 28409554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrantly expressed snoRNA, snRNA, piRNA and tRFs in canine melanoma.
    Rahman MM; Lai YC; Husna AA; Chen HW; Tanaka Y; Kawaguchi H; Hatai H; Miyoshi N; Nakagawa T; Fukushima R; Miura N
    Vet Comp Oncol; 2020 Sep; 18(3):353-361. PubMed ID: 31769925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.
    Wang W; Liu M; Guan Y; Wu Q
    Med Sci Monit; 2016 Jun; 22():2126-32. PubMed ID: 27327120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6.
    Fang Y; Sun B; Xiang J; Chen Z
    Cell Physiol Biochem; 2015; 35(1):227-36. PubMed ID: 25591765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
    Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
    Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
    Chen Z; Chen LY; Dai HY; Wang P; Gao S; Wang K
    J Cell Biochem; 2012 Oct; 113(10):3229-35. PubMed ID: 22628193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1.
    Dong K; Du Q; Cui X; Wan P; Kaltenmeier C; Luo J; Yan B; Yan Y; Geller DA
    Biochem Biophys Res Commun; 2020 Apr; 524(2):273-279. PubMed ID: 31987500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of Urothelial Carcinoma-Associated 1 Suppressed Cell Growth and Migration Through Regulating miR-301a and CXCR4 in Osteosarcoma MHCC97 Cells.
    Zhu G; Liu X; Su Y; Kong F; Hong X; Lin Z
    Oncol Res; 2018 Dec; 27(1):55-64. PubMed ID: 29523218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN.
    Zhang N; Liu JF
    Bioengineered; 2020 Dec; 11(1):972-983. PubMed ID: 32970954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.